Home Treatment Versus Early Discharge From the Hospital: A Dilemma in the Management of Proximal Vein Thrombosis With Low Molecular Weight Heparins

Abstract

Get full access to this article

View all access options for this article.

References

Hirsh J. , Levine MN Low molecular weight heparin. Blood 1992 ;79: 1.

Weitz J. , Hirsh J. New anticoagulant strategies. J Lab Clin Med 1993;122:364-73.

Lensing AW , Prins MH , Davidson BL , Hirsh J. Treatment of deep venous thrombosis with low molecular-weight heparins: a meta-analysis. Arch Intern Med 1995;155.:601-7.

Prandoni P. , Lensin-g,WA Batter HR , et al. Comparisation of subeutaneous low-molecular weight heparin with intravenous standard heparin in proximal vein thrombosis. Lancet 1992;339:441-5.

Leizorovtcz A. , Simmoneau G. , Decousus H. , Boisset JP Comparison of efficacy and safety of tow molecular weight heparins and unfractioned heparin in initial treatment of deep venous thrombosis: a meta-analysis. Br Med J 1994 ; 309:299-304.

Levine M. , Gant M. , Hirsh J. A comparison of low-molecular weight heparin administered primarily at home with unfractioned hephtin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996;334:677-81.

Koopman Mmw , Prandoni P. , Piovella P. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin at home. N Engl J Med 1996:334:682-7.

Schafer AI Low molecular weight heparin. An opportunity for home treatment of venous thrombosis. N Engl J Med 1996;334:724-5.